Download This PaperRegulators Could Allow Early Use of COVID-19 Vaccine or Treatment
7 Pages Posted: 7 Apr 2020
Date Written: March 24, 2020
Abstract
Quickly developed therapeutic, prophylactic, and vaccine treatments will be essential to defeat the COVID-19 pandemic. Standard regulatory and development protocols typically yield drug development in 6 to 11 years. However, experimental vaccines and prophylactics against COVID-19 are in development and currently in trials, making deployment after safety trials feasible within months. Though efficacy of these treatments is uncertain, with probability of success, on average, at just 16 percent, efficacy can still be tested in real-world settings by adopting an approach that allows patients to begin drug treatments earlier in the regulatory process.
Keywords: immunization, vaccines, healthcare, coronavirus, coronavirus pandemic, COVID-19, public health, economics, quarantine, economy, economic crisis
JEL Classification: I00, I18
Suggested Citation: Suggested Citation